Comparison of broth microdilution, agar dilution, and Etest for susceptibility testing of doripenem against gram-negative and gram-positive pathogens

Journal of Clinical Microbiology

Volumn 48, Issue 9, 2010, Pages 3353-3357

  Amsler, K ^a   Santoro, C ^a   Foleno, B ^a   Bush, K ^b   Flamm, R ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DORIPENEM;

ACINETOBACTER BAUMANNII; AGAR DILUTION; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BETA HEMOLYTIC STREPTOCOCCUS; BROTH DILUTION; CITROBACTER; CITROBACTER FREUNDII; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENTEROBACTER CLOACAE; ENTEROBACTER SAKAZAKII; ENTEROBACTERIACEAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EPSILOMETER TEST; ESCHERICHIA COLI; HAFNIA ALVEI; INTERMETHOD COMPARISON; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROTEUS PENNERI; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; STAPHYLOCOCCUS SAPROPHYTICUS; STAPHYLOCOCCUS SIMULANS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS BOVIS; STREPTOCOCCUS CONSTELLATUS; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SALIVARIUS;

ANTI-BACTERIAL AGENTS; CARBAPENEMS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS;

NEGIBACTERIA; POSIBACTERIA;

EID: 77956836391     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00494-10     Document Type: Article

References (9)

1. Amsler, K., C. Santoro, B. Foleno, E. Wira, and R. Flamm. 2007. Validation of dry-form broth microdilution panels for susceptibility testing of doripenem and comparison of agar dilution susceptibilities, abstr. D-237. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., Chicago, IL.
2. Badal, R., J. Johnson, D. Hoban, M. Hackel, A. Johnson, S. Bouchillon, B. Johnson, A. Evangelista, and Y. C. Yee. 2008. Reliability of Etest for doripenem (DOR) susceptibility testing of Pseudomonas aeruginosa isolates with MICs near the susceptible breakpoint of 2 mcg/ml, abstr. A-009. Abstr. 108th Gen. Meet. Am. Soc. Microbiol., Boston, MA.
3. Castanheira, M., R. N. Jones, and D. M. Livermore. 2009. Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp. Diagn. Microbiol. Infect. Dis. 63:426-433.
4. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 7th ed., vol. 26, no. 2. Approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 17th informational supplement, vol. 27, no. 1. M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; 19th informational supplement, vol. 29, no. 3. M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Ge, Y., M. A. Wikler, D. F. Sahm, R. S. Blosser-Middleton, and J. A. Karlowsky. 2004. In vitro antimicrobial activity of doripenem, a new carbapenem. Antimicrob. Agents Chemother. 48:1384-1396.
8. Jones, R. N., H. K. Huynh, D. J. Biedenbach, T. R. Fritsche, and H. S. Sader. 2004. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations. J. Antimicrob. Chemother. 54:144-154.
9. Marti, S., J. Sánchez-Céspedes, V. Alba, and J. Vila. 2009. In vitro activity of doripenem against Acinetobacter baumannii clinical isolates. Int. J. Antimicrob. Agents 33:181-182.